154 related articles for article (PubMed ID: 25222780)
1. Expression of galectin-3 in gastric adenocarcinoma.
Gomes TS; Oshima CT; Forones NM; De Oliveira Lima F; Ribeiro DA
Indian J Med Res; 2014 Jul; 140(1):69-76. PubMed ID: 25222780
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
Ajani JA; Estrella JS; Chen Q; Correa AM; Ma L; Scott AW; Jin J; Liu B; Xie M; Sudo K; Shiozaki H; Badgwell B; Weston B; Lee JH; Bhutani MS; Onodera H; Suzuki K; Suzuki A; Ding S; Hofstetter WL; Johnson RL; Bresalier RS; Song S
Br J Cancer; 2018 Jan; 118(1):52-61. PubMed ID: 29136404
[TBL] [Abstract][Full Text] [Related]
4. CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance.
Bektas S; Bahadir B; Ucan BH; Ozdamar SO
Pathol Oncol Res; 2010 Dec; 16(4):569-77. PubMed ID: 20177845
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patients.
Yang XB; Zhao JJ; Huang CY; Wang QJ; Pan K; Wang DD; Pan QZ; Jiang SS; Lv L; Gao X; Chen HW; Yao JY; Zhi M; Xia JC
PLoS One; 2013; 8(10):e78158. PubMed ID: 24194912
[TBL] [Abstract][Full Text] [Related]
6. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
[TBL] [Abstract][Full Text] [Related]
7. CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases.
Coppin L; Benomar K; Corfiotti F; Cattan S; Renaud F; Lapere C; Leteurtre E; Vantyghem MC; Truant S; Pigny P
Pancreatology; 2016; 16(1):115-20. PubMed ID: 26613889
[TBL] [Abstract][Full Text] [Related]
8. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
9. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients).
Arfaoui-Toumi A; Kria-Ben Mahmoud L; Ben Hmida M; Khalfallah MT; Regaya-Mzabi S; Bouraoui S
Bull Cancer; 2010 Feb; 97(2):E1-8. PubMed ID: 20080461
[TBL] [Abstract][Full Text] [Related]
10. [Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer].
Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):151-4. PubMed ID: 16155829
[TBL] [Abstract][Full Text] [Related]
11. Immunoexpression of galectin-3 in colorectal cancer and its relationship with survival.
Zaia Povegliano L; Oshima CT; de Oliveira Lima F; Andrade Scherholz PL; Manoukian Forones N
J Gastrointest Cancer; 2011 Dec; 42(4):217-21. PubMed ID: 20635166
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression.
Kim SJ; Choi IJ; Cheong TC; Lee SJ; Lotan R; Park SH; Chun KH
Gastroenterology; 2010 Mar; 138(3):1035-45.e1-2. PubMed ID: 19818782
[TBL] [Abstract][Full Text] [Related]
13. Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation.
Baldus SE; Zirbes TK; Weingarten M; Fromm S; Glossmann J; Hanisch FG; Mönig SP; Schröder W; Flucke U; Thiele J; Hölscher AH; Dienes HP
Tumour Biol; 2000; 21(5):258-66. PubMed ID: 10940822
[TBL] [Abstract][Full Text] [Related]
14. Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer.
Yang J; Zhu L; Cai Y; Suo J; Jin J
Int J Oncol; 2014 Sep; 45(3):1313-20. PubMed ID: 24919464
[TBL] [Abstract][Full Text] [Related]
15. [Study on the expression and significance of Galectin-3 and CDC25B mRNA in human gastric carcinoma].
Zhang XM; Yao GY; Zhang BY; Wang LL; Zhao M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):288-92. PubMed ID: 19504441
[TBL] [Abstract][Full Text] [Related]
16. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
Chen J; Tang D; Wang S; Li QG; Zhang JR; Li P; Lu Q; Niu G; Gao J; Ye NY; Wang DR
Tumour Biol; 2014 Mar; 35(3):2513-9. PubMed ID: 24241899
[TBL] [Abstract][Full Text] [Related]
17. Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren's classification system.
Lorenzon L; Cippitelli C; Avantifiori R; Uccini S; French D; Torrisi MR; Ranieri D; Mercantini P; Canu V; Blandino G; Cavallini M
J Surg Oncol; 2017 Aug; 116(2):184-194. PubMed ID: 28475823
[TBL] [Abstract][Full Text] [Related]
18. Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion.
Nakayama T; Hirakawa H; Shibata K; Abe K; Nagayasu T; Taguchi T
Oncol Rep; 2010 Sep; 24(3):599-606. PubMed ID: 20664963
[TBL] [Abstract][Full Text] [Related]
19. Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer.
Dong WG; Yu QF; Xu Y; Fan LF
Dig Dis Sci; 2008 Jul; 53(7):1811-7. PubMed ID: 17999183
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer.
Kim SJ; Shin JY; Cheong TC; Choi IJ; Lee YS; Park SH; Chun KH
Clin Exp Metastasis; 2011 Dec; 28(8):743-50. PubMed ID: 21750908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]